✦ LIBER ✦

Prognostic factors for a subsequent basal cell carcinoma: implications for follow-up

✍ Scribed by V. Madan; P.R. Hoban; R.C. Strange; A.A. Fryer; J.T. Lear

Book ID: 108668855
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 156 KB
Volume: 155
Category: Article
ISSN: 0007-0963
DOI: 10.1111/j.1365-2133.2006.07296.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic factors for a subsequent basa

Prognostic factors for a subsequent basal cell carcinoma: implications for follow-up

✍ C.A. Van Iersel; H.V.N. Van de Velden; C.D.J. Kusters; P.H.M. Spauwen; W.A.M. Bl 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB

Need for specialist follow-up of patient

Need for specialist follow-up of patients with basal cell carcinoma

✍ Terrilea S. Burnett; D.J. Elpern 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

Genetics and risk factors for basal cell

Genetics and risk factors for basal cell carcinoma

✍ V. Madan; P. Hoban; R. C. Strange; A. A. Fryer; J. T. Lear 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB

Preoperative radiotherapy for muscle-inv

Preoperative radiotherapy for muscle-invasive bladder carcinoma. Long term follow-up and prognostic factors for 338 patients

✍ Alan Pollack; Gunar K. Zagars; Colin P. Dinney; David A. Swanson; Andrew C. von 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 778 KB

Formalin-fixed tissue Mohs surgery (slow

Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data

✍ C.M. Lawrence; M. Haniffa; M.G.C. Dahl 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

Basal cell and squamous cell carcinomas

Basal cell and squamous cell carcinomas are important risk factors for cutaneous malignant melanoma. Screening implications

✍ Ashfaq A. Marghoob; Johnny Slade; Thomas G. Salopek; Alfred W. Kopf; Robert S. B 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 770 KB

Background. This study was designed to determine the risk of developing malignant melanoma (MM) in patients with a history of basal cell and/or squamous cell skin cancer (BCC/SCC) and to determine whether surveillance efforts can be directed toward these patients for the detection of early MMs. Met